# Kura Oncology, Inc. (KURA): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/kura for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in comb...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $9.61 USD |
| Market Cap | $854.9M |
| P/E (TTM) | — |
| EPS (TTM) | −$3.37 |
| 52-Week Range | $7.36 – $13.90 |
| Dividend Yield (TTM) | — |

## Dividend

KURA has no dividend payment history in our records.

## Frequently Asked Questions

### What does Kura Oncology, Inc. do?

Kura Oncology, Inc. (KURA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is KURA's market cap?

Kura Oncology, Inc. (KURA) has a market capitalization of approximately $854.9 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does KURA pay a dividend?

No, Kura Oncology, Inc. (KURA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is KURA profitable?

Kura Oncology, Inc. (KURA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has KURA ever paid a dividend?

No. Dividend Data's records show no dividend payments from Kura Oncology, Inc. (KURA). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/kura
- Dividend history & safety: https://www.dividenddata.com/stocks/kura/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/kura/earnings
- Financial statements: https://www.dividenddata.com/stocks/kura/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/kura/valuation
- Peer comparison: https://www.dividenddata.com/stocks/kura/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.